Noom

Last Reported Valuation
$3.7B
Series F, May 2021
Total Funding Raised
$669M+
As of May 2021
Founded
2008
New York, NY
Exchange Listing
Private
Not publicly traded
Book a Call — FNEX Ventures Fund

About Noom

Noom is a leading digital health platform focused on chronic disease prevention, weight management, and behavior change. Founded in 2008 by Saeju Jeong and Artem Petakov in New York City, Noom has raised approximately $669 million in total funding and reached a $3.7 billion valuation following its Series F in May 2021. The company's psychology-based approach to sustainable weight loss has grown it to approximately 1.5 million paid subscribers and an estimated $1 billion in annual recurring revenue as of 2023 — making it the top-funded company in its competitive category.

Noom's platform combines behavioral science, personalized coaching, and AI-driven tools to help users build lasting healthy habits. In 2024–2025, the company made a major strategic expansion into GLP-1 medications, launching Noom Med — a clinical weight loss program pairing GLP-1 prescriptions with Noom's behavioral platform — and following it with the Noom Microdose GLP-1Rx Program in August 2025, which delivers personalized low-dose GLP-1 therapy at $99 to start. The GLP-1Rx program reached a $100 million annual run-rate within four months of its September 2024 launch. Medical and behavioral plans now account for approximately 60% of Noom's revenue.

As of late 2025, Noom is achieving positive EBITDA and free cash flow with a strong cash position and no debt — a significant milestone for a company that bootstrapped for much of its first decade. The company has integrated with LillyDirect, partnered with Highmark to serve nearly 2 million eligible members, and expanded enterprise distribution through Castlight Health. A Goldman Sachs-led IPO was explored in 2021 but paused due to market conditions; Noom continues to be cited as a likely IPO candidate as digital health market conditions improve.

Funding History

Round Date Amount Raised Post-Money Valuation Notable Investors
Series F May 2021 $540M ~$3.7B Silver Lake, Novo Holdings, Oak HC/FT, Temasek, Sequoia Capital, RRE Ventures, existing investors
Series E Jun 2019 $58M Undisclosed Sequoia Capital, RRE Ventures
Series D Mar 2019 $29M Undisclosed Sequoia Capital, RRE Ventures
Series C 2017 $20M Undisclosed Sequoia Capital, RRE Ventures
Series B 2016 $13M Undisclosed RRE Ventures, existing investors
Series A 2014 ~$5M Undisclosed RRE Ventures

Figures sourced from public disclosures. Approximate. For informational purposes only. Not an offer or solicitation.

Company Details

Legal Name
Noom, Inc.
Headquarters
New York, NY
Founded
2008
Sector
Digital Health
Sub-Sector
HealthTech / GLP-1 / Wellness
Flagship Product
Noom Weight / Noom Med
Entity Type
Private Corporation
Employees
~1,200
Exchange Listing
IPO Planned (TBD)

Noom Stock FAQs

No. Noom is a private company. In 2021, Noom was reported to have hired Goldman Sachs to explore a public listing, but those plans were paused due to cooling IPO market conditions in 2022–2023. The company has since focused on a path to profitability, achieving positive EBITDA by late 2025. As of June 2026, no formal IPO filing has been made. Accredited investors interested in pre-IPO exposure to Noom may explore the FNEX Ventures Fund, subject to eligibility and availability.
Noom's last publicly reported post-money valuation was approximately $3.7 billion, established at the time of its $540 million Series F round in May 2021. The company has not disclosed a more recent formal valuation, though secondary market data has tracked the $3.7 billion figure into 2025. Private company valuations are based on the terms of recent financing rounds and are not indicative of current market value or future performance.
Noom's Series F was anchored by Silver Lake, a leading technology-focused private equity firm, alongside Novo Holdings (the investment arm of the Novo Nordisk Foundation), Temasek (Singapore's state investment company), and Oak HC/FT, a healthcare-focused growth equity firm. Long-standing backer Sequoia Capital has participated in multiple rounds. These are strategic and financial relationships and do not guarantee any particular performance outcome.
FNEX Ventures Fund

Access Pre-IPO AI Companies Through FNEX Ventures Fund

The FNEX Ventures Fund provides accredited investors with diversified exposure to high-growth private technology and digital health companies — including positions in companies like Noom — through a single professionally managed private fund vehicle.

Book a Call Learn About the Fund

Securities offered through FNEX Capital, LLC, member FINRA & SIPC. This material does not constitute an offer to sell nor a solicitation of an offer to buy any security. Such offers can be made only by the confidential Private Placement Memorandum (the "Memorandum"). Please read the entire Memorandum paying special attention to the risk section prior to investing. Available only to accredited investors. FNEX Ventures is required to verify accreditation status prior to accepting any investment.

This is a private company. Its shares are not publicly traded and no market pricing is provided on this page. All valuation figures are based on publicly reported funding round data and are not indicative of current market value, intrinsic value, or future performance. Private company valuations are inherently uncertain and may change materially over time.

Company names, logos, and trademarks referenced or displayed on this page are used for illustrative purposes only and do not represent actual holdings, target investments, or future investment intentions of the FNEX Ventures Fund. There is no guarantee that any portfolio company will complete an initial public offering (IPO), merger, acquisition, or other liquidity event. Investment in private funds involves a high degree of risk, including the possible loss of the entire investment. Past performance is not indicative of future results.

Related Articles